Literature DB >> 12639489

Immune response and protection elicited by DNA immunisation against Taenia cysticercosis.

Qing-min Wang1, Shu-han Sun, Zhen-lin Hu, Dan Wu, Zhong-chuan Wang.   

Abstract

The study evaluated DNA vaccination in Taenia solium cysticercosis prevention by using cDNA of an antigen (cC1) from T. solium metacestode. pcDNA3-cC1 DNA vaccine was constructed by inserting the cDNA into the eukaryotic expression plasmid pcDNA3. Positive expression of the pcDNA3-cC1 product was confirmed by its transfection into COS7 cell and enzyme-linked immunoabsorbent assay using serum of pigs infected with T. solium metacestode. Immunisation of BALB/c mice with three injections of pcDNA3-cC1 induced antigen-specific immune responses of the Th1 phenotype. Inoculation of new-born pigs induced protection against challenge with T. solium by 73.3% reduction of the metacestode number. Antibodies elicited by DNA immunisation with pcDNA3-cC1 specifically reacted with native cC1 protein, which was mainly restricted to the cyst wall of T. solium metacestode. Positive apoptosis signals were also detected in the cyst wall cells of metacestode slices from pigs immunised with pcDNA3-cC1 by TUNEL staining method. Those suggested that apoptosis played a role in protecting pigs immunised with pcDNA3-cC1 nucleic acid vaccine from pathogen challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639489     DOI: 10.1016/s0264-410x(02)00661-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.

Authors:  Carlos F Solís; Pedro Ostoa-Saloma; Verónica H Lugo-Martínez; Stephen Albert Johnston; Juan Pedro Laclette
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Laura A Kerepesi; Paul B Keiser; Thomas J Nolan; Gerhard A Schad; David Abraham; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.

Authors:  Ana Flisser; Charles G Gauci; André Zoli; Joel Martinez-Ocaña; Adriana Garza-Rodriguez; Jose Luis Dominguez-Alpizar; Pablo Maravilla; Rossana Rodriguez-Canul; Guillermina Avila; Laura Aguilar-Vega; Craig Kyngdon; Stanny Geerts; Marshall W Lightowlers
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.

Authors:  Elizabeth Monreal-Escalante; Dania O Govea-Alonso; Marisela Hernández; Jacquelynne Cervantes; Jorge A Salazar-González; Andrea Romero-Maldonado; Gabriela Rosas; Teresa Garate; Gladis Fragoso; Edda Sciutto; Sergio Rosales-Mendoza
Journal:  Planta       Date:  2015-11-27       Impact factor: 4.116

5.  Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis.

Authors:  Xuepeng Cai; Gailing Yuan; Yadong Zheng; Xuenong Luo; Shaohua Zhang; Juntao Ding; Zhizhong Jing; Chengping Lu
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.